Clinical trial
Lung Cancer Biomarkers and Screening
NCT00301119 · NYU Langone Health, Other · Recruiting
Key facts
| NCT number | NCT00301119 |
|---|---|
| Title | Lung Cancer Biomarkers and Screening |
| Official title | NYU Lung Cancer Biomarker Center |
| Acronym | NYULCBC |
| Lead sponsor | NYU Langone Health, Other |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Lung Cancer |
| Enrollment | 10,850 |
| Start date | May 1, 2000 |
| Primary completion | May 1, 2030 |
| Completion | May 1, 2030 |
| First posted | Mar 10, 2006 |
| Last update posted | Jun 26, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: